New oral anticoagulants (NOAC) and liver injury

J Hepatol. 2014 Aug;61(2):198-9. doi: 10.1016/j.jhep.2014.05.010. Epub 2014 May 15.

Authors

Nicholas Moore¹, Patrick Blin², Sinem-Ezgi Gulmez²

Affiliations

¹ Université de Bordeaux, INSERM U657, INSERM CIC1401, Bordeaux, France. Electronic address: nicholas.moore@pharmaco.u-bordeaux2.fr.
² Université de Bordeaux, INSERM U657, INSERM CIC1401, Bordeaux, France.

PMID: 24837361
DOI: 10.1016/j.jhep.2014.05.010

No abstract available

Publication types

Editorial
Comment

MeSH terms

Chemical and Drug Induced Liver Injury / etiology*
Factor Xa Inhibitors / adverse effects*
Female
Humans
Male
Morpholines / adverse effects*
Rivaroxaban
Thiophenes / adverse effects*

Substances

Factor Xa Inhibitors
Morpholines
Thiophenes
Rivaroxaban